BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25684485)

  • 1. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
    Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
    Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
    Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
    J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
    Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
    Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
    Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
    Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered methylation of multiple genes in carcinogenesis of the prostate.
    Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
    Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.
    Russo AL; Thiagalingam A; Pan H; Califano J; Cheng KH; Ponte JF; Chinnappan D; Nemani P; Sidransky D; Thiagalingam S
    Clin Cancer Res; 2005 Apr; 11(7):2466-70. PubMed ID: 15814621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer.
    Branham MT; Campoy E; Laurito S; Branham R; Urrutia G; Orozco J; Gago F; Urrutia R; Roqué M
    Breast Cancer Res Treat; 2016 Jan; 155(1):13-23. PubMed ID: 26610810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression.
    Bhat A; Masood A; Wani KA; Bhat YA; Nissar B; Khan NS; Ganai BA
    Tumour Biol; 2017 Apr; 39(4):1010428317697563. PubMed ID: 28443466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis.
    Lee JS
    Virchows Arch; 2007 Jun; 450(6):637-42. PubMed ID: 17479284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.
    Su PF; Huang WL; Wu HT; Wu CH; Liu TY; Kao SY
    Oral Oncol; 2010 Oct; 46(10):734-9. PubMed ID: 20729138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer.
    Sayed-Ahmed MM; Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Aleisa AM; Al-Yahya AA; Alsheikh A; Al Diab AI; Al-Akeely MH
    Tumori; 2013; 99(4):545-54. PubMed ID: 24326846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
    Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.